当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析 - 现金流量表

皓元医药

(688131)

  

流通市值:124.82亿  总市值:124.82亿
流通股本:2.12亿   总股本:2.12亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金551,423,146.772,282,090,487.331,610,725,771.041,035,284,363.96
  收到的税费返还6,393,996.2629,749,559.9419,061,320.6412,962,140.64
  收到其他与经营活动有关的现金23,618,227.6948,177,460.8624,559,495.069,428,511.99
  经营活动现金流入小计581,435,370.722,360,017,508.131,654,346,586.741,057,675,016.59
  购买商品、接受劳务支付的现金285,102,550.09847,542,881.66648,812,006.27451,640,532.18
  支付给职工以及为职工支付的现金206,972,753.68771,241,346.76578,383,021.61394,381,577.54
  支付的各项税费59,721,090.17141,755,834.23100,995,020.5335,922,018.22
  支付其他与经营活动有关的现金62,140,653.21217,517,187.17167,148,497.8198,631,108.38
  经营活动现金流出小计613,937,047.151,978,057,249.821,495,338,546.22980,575,236.32
  经营活动产生的现金流量净额-32,501,676.43381,960,258.31159,008,040.5277,099,780.27
二、投资活动产生的现金流量:
  收回投资收到的现金1,069,000,00023,000,00015,000,00015,000,000
  取得投资收益收到的现金2,787,739.7412,887.67--
  处置固定资产、无形资产和其他长期资产收回的现金净额2,306,477.596,344,531.854,913,172.041,778,889.08
  投资活动现金流入小计1,074,094,217.3329,357,419.5219,913,172.0416,778,889.08
  购建固定资产、无形资产和其他长期资产支付的现金88,557,176.63304,462,662.44187,818,409.29182,142,522.91
  投资支付的现金922,500,000499,748,947.22,500,0002,500,000
  取得子公司及其他营业单位支付的现金-8,800,0008,800,0008,800,000
  投资活动现金流出小计1,011,057,176.63813,011,609.64199,118,409.29193,442,522.91
  投资活动产生的现金流量净额63,037,040.7-783,654,190.12-179,205,237.25-176,663,633.83
三、筹资活动产生的现金流量:
  吸收投资收到的现金-44,017,353.8542,795,377.534,000,000
  其中:子公司吸收少数股东投资收到的现金-34,000,00034,000,00034,000,000
  取得借款收到的现金291,805,529.861,589,558,358.36562,244,642.29347,165,513.53
  筹资活动现金流入小计291,805,529.861,633,575,712.21605,040,019.79381,165,513.53
  偿还债务支付的现金118,165,086.88737,749,112.43488,345,529.79272,295,739.29
  分配股利、利润或偿付利息支付的现金6,348,625.9447,043,968.6144,248,860.536,790,613.9
  支付其他与筹资活动有关的现金12,358,912.9457,304,104.2235,967,171.5525,057,403.71
  筹资活动现金流出小计136,872,625.76842,097,185.26568,561,561.84334,143,756.9
  筹资活动产生的现金流量净额154,932,904.1791,478,526.9536,478,457.9547,021,756.63
四、汇率变动对现金及现金等价物的影响8,134,951.467,845,113.984,215,590.655,893,201.64
五、现金及现金等价物净增加额193,603,219.83397,629,709.1220,496,851.87-46,648,895.29
  加:期初现金及现金等价物余额873,095,672.73475,465,963.61475,465,963.61475,465,963.61
  期末现金及现金等价物余额1,066,698,892.56873,095,672.73495,962,815.48428,817,068.32
补充资料:
  净利润-197,930,034.58-68,918,893.5
  资产减值准备-131,359,593.72-49,903,371.19
  固定资产和投资性房地产折旧-110,815,258.91-50,709,516.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-110,815,258.91-50,709,516.18
  无形资产摊销-9,014,639.61-4,251,267.12
  长期待摊费用摊销-28,271,022.01-14,022,250.61
  处置固定资产、无形资产和其他长期资产的损失-567,191.03-30,736.19
  固定资产报废损失-17,909.22-1,851.89
  公允价值变动损失--150,068.49--
  财务费用-36,410,144.92-14,244,775
  投资损失-13,757,656.87-5,245,231.45
  递延所得税--45,398,098.93--32,603,336.52
  其中:递延所得税资产减少--30,614,828.23--31,823,313.98
    递延所得税负债增加--14,783,270.7--780,022.54
  存货的减少--145,864,424.76--5,603,268.44
  经营性应收项目的减少--104,595,289.47--118,203,051.93
  经营性应付项目的增加-65,205,154.69--19,181,758.62
  其他-25,395,817.89-17,594,592.37
  现金的期末余额-873,095,672.73-428,817,068.32
  减:现金的期初余额-475,465,963.61-475,465,963.61
  现金及现金等价物的净增加额-397,629,709.12--46,648,895.29
公告日期2025-04-302025-03-282024-10-302024-08-29
审计意见(境内)标准无保留意见
TOP↑